Navigation Links
FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Date:9/5/2007

Changes Would Cost Medicare System Billions

As Seniors Seek Conventional Treatments Instead

WASHINGTON, Sept. 5 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) is preparing new guidelines that threaten new, costly regulation of complementary and alternative medicines (CAM), used by 74.6 percent of adults at some point in their lives. The FDA guidance would define a product based on its "intended use." If vegetable juice were sold to satisfy thirst, for example, it would not be regulated, while if it were used to treat a medical condition (e.g. dehydration), it would be.

Under the guidelines, all items used for medicinal purposes -- including juices, lotions, vitamins and minerals -- could become more expensive and less available. As a result, millions of seniors may be forced to choose conventional treatments within the Medicare system instead of CAM paid for at their own expense, costing taxpayers unnecessary billions.

The FDA proposal, titled, "Draft Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration," will represent the FDA's official thinking on this topic when finalized, but will not become regulatory policy. However, Congressional investigations frequently have found these types of guidance documents to be "intended to bypass the rulemaking process."

Complementary therapies might include aromatherapy to lessen a patient's discomfort during surgery; alternative therapies might include a special diet to treat cancer instead of chemotherapy. According to the National Institutes of Health, 74.6 percent of adults have used CAM at some point; a 2006 survey finds that close to two-thirds of adults over the age of 50 have used some form of CAM. The Centers for Disease Control estimated that the U.S. public spent between $36 billion and $47 billion on CAM therapies in 1997 alone.

"These changes mean that consumers will be less likely to be able to treat themselves without excessive government interference," said Shannon Benton, executive director of The Senior Citizens League. "Seniors who previously saved money by treating themselves with vitamins, lotions, or protein shakes may now need a prescription -- forcing them to bill Medicare for conventional medical treatments, costing the American taxpayer billions of dollars."

The Senior Citizens League (TSCL) filed comments with the FDA in May protesting the impending guidance. In its comments, TSCL wrote, "Currently, few CAM approaches are reimbursed by Medicare and are therefore paid out of pocket by the consumer. On the other hand, if vitamins and minerals were regulated as 'drugs,' Medicare might be required to pay for those same vitamins and minerals. Such a simple change in status for CAM theoretically could cost the Federal Government billions of dollars annually."

Medicare's trustees forecast that the Medicare trust fund will be exhausted by 2019. The FDA's new proposal risks bankrupting Medicare's trust funds even sooner.

"On behalf of its 1.2 million supporters, The Senior Citizens League is advocating for ways to ensure the long-term stability of Medicare," said Ralph McCutchen, chairman of The Senior Citizens League. "Not only does this secret plan threaten to bankrupt Medicare even sooner, but it takes choices away from seniors when they need them most."

With 1.2 million members, The Senior Citizens League is one of the nation's largest nonpartisan seniors groups. The Senior Citizens League is a proud affiliate of The Retired Enlisted Association. Visit http://www.SeniorsLeague.org for more information.


'/>"/>
SOURCE The Senior Citizens League
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Consumer group seeks Sibutramine ban
2. Gujarat Seeks To Scale Down Infant Mortality Rate
3. Europe Seeks Indian Expertise
4. Book Seeks To Rehabilitate Soldiers
5. Government Seeks To Wipe Out Prostitution
6. Multiple Sclerosis Patient Seeks Help of Stem Cells
7. Pro-reservation body seeks removal of AIIMS Director
8. AIIMS Doctors Seeks Ramadoss Intervention For Venugopal’s Remova
9. Human Chain Seeks AIIMS Status For Tiruchi Medical College
10. Harney Seeks Approval for New Medical Practitioners Bill
11. Drug Company Seeks Approval for Human Testing of Vaccine against H5N1 Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
(Date:6/23/2016)... MEDIA, Pa. , June 23, 2016 ... treatments in an outpatient dialysis facility.  Treatments are usually ... to 6 hours per visit, including travel time, equipment ... on a patient, but especially grueling for patients who ... residents of a skilled nursing and rehabilitation centers for ...
(Date:6/23/2016)... 23, 2016 The Biotechnology industry ... to present great opportunities to investors. Stock-Callers.com assesses the ... Corp. (NYSE: XON ), Vertex Pharmaceuticals Inc. ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... and receive your complimentary trade alerts at: ...
Breaking Medicine Technology: